The 80th Annual Meeting of the Japanese Society of Hematology

Presentation information

Oral Session

Oral Session 1-13D CML: Basic/Clinical

Fri. Oct 12, 2018 4:20 PM - 5:20 PM No.13 (Osaka International Convention Center, 11F 1101-2)

Chair: Hideo Tanaka (Department Hematology& Oncology, Hiroshima City Asa Hospital, Japan)

[OS1-13D-4] Introduction of T315I into Ph+ leukemia cell lines by homologous recombination using CRISPR/Cas9

Takeshi Inukai1, Minori Tamai1, Satoru Kojika1, Masako Abe1, Keiko Kagami1, Daisuke Harama1, Tamao Shinohara1, Atsushi Watanabe1, Hiroko Oshiro1, Koshi Akahane1, Kumiko Goi1, Eiji Sugihara2, Shinichiro Nakada3, Kanji Sugita1 (1.Department of Pediatrics, University of Yamanashi, Yamanashi, Japan, 2.Innovation Medical Research Institute, University of Tsukuba, Japan, 3.Department of Bioregulation and Cellular Response, Osaka University, Japan)

Abstract password authentication.
Password is written on a program and abstract book.

Password